SHANDONG BINZHOU ZHIYUAN BIOTECHNOLOGY CO LTD
Binzhou Zhiyuan Biotechnology specialize in production of Pharmaceutical excipients, Hydroxypropyl betadex and betadex sulfobutyl ether sodium have obtained DMF from FDA
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Product Name: Betadex Sulfobutyl Ether Sodium
Synonyms: Sulfobutyl Ether-Beta-Cyclodextrin Sodium Salt;
Sulfobutyl Ether-β-Cyclodextrin Sodium Salt.
CASNo.:182410-00-0
DMF NO.: 030167
Quality: Injection Grade
Standard: USP/EP
Characteristics & Applications:
Betadex Sulfobutyl Ether Sodium is a high water-soluble anionic cyclodextrin derivative. It can easily form non-covalent inclusion complexes with drug molecules, thus it has good performance in enhancing drug stability, solubility and safety, reducing drug toxicity and hemolysis, covering up bad smell, and controlling drug release rate.
Betadex Sulfobutyl Ether Sodium has been used in injection, oral, nasal and eye medication. Modification by charged functional units can improve the binding affinity of cyclodextrins for oppositely charged guest molecular, so it has a special affinity for drugs with nitrogen elements
Specifications:
CAS # | 182410-00-0 |
Molecular Formula | C42H70-nO35 (C4H8O3S Na)n |
Molecular Weight | 1135+158n |
Clarity of Solution | 30%(w/v) solution is clear and essentially free from particles of foreign matter |
Assay | 95.0%-105.0% |
Average Degree of Substitution | 6.2-6.9 |
BetaCyclodextrin Content | ≤0.1% |
TAMC (cfu/g) | ≤100cfu/g |
TYMC (cfu/g) | ≤50cfu/g |
Escherichia Coli | Absence |
Bacterial endotoxins | ≤20EU/g |
